Italfarmaco Group Announces Positive Topline Data from Phase

Italfarmaco Group Announces Positive Topline Data from Phase 3 Trial Showing Beneficial Effect of Givinostat in Patients with Duchenne Muscular Dystrophy

Italfarmaco Group Announces Positive Topline Data from Phase 3 Trial Showing Beneficial Effect of Givinostat in Patients with Duchenne Muscular Dystrophy
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Rome , Lazio , Italy , San Diego , California , United States , University Of California Davis , Craig Mcdonald , Paolo Bettica , Eugenio Mercuri , Laura Mittmann , Jacob Verghese , Santa Lucia Foundation , Drug Administration , Department Of Pediatrics , Italfarmaco Group , Trophic Communications , Catholic University , Duchenne Muscular Dystrophy , Chief Medical Officer , Parent Project Muscular Dystrophy , Rare Pediatric Disease , Orphan Drug Designation , Fast Track , Clinical Results , Secondary Endpoints , North Star Ambulatory Assessment , Magnetic Resonance Spectroscopy , Adverse Events , Paediatric Neurology , Physical Medicine , Lorenzo Puri , Sanford Burnham Prebys Medical Research Institute , Parent Project , Neuromuscular Disorders ,